Treatment with gene therapy candidate BB-301 led to improvements in swallowing ability for the first three OPMD patients in a clinical trial.

The gene therapy BBM-H901 (dalnacogene ponparvovec) has been approved in China for adults with moderate to severe hemophilia ...